Clinical Study Report (CSR) Design for Long-Acting Injectable Antipsychotic Pivotal Trials

A well-organized Clinical Study Report is how a reviewer actually forms their judgment of a trial's conduct and results; the report's structure is not merely an administrative formality layered on top of the data, it is the lens through which that data is interpreted (International Council for Harmonisation, 1996). This article examines Clinical Study Report design for a representative long-acting injectable antipsychotic pivotal trial, a drug category whose dosing structure, relapse-prevention efficacy design, and injection-site safety profile each place distinctive demands on specific sections of the ICH E3 report structure.